Taiwan has a good chance to play an important role in the biotechnology industry if the nation can effectively integrate its medical research infrastructure with its strengths in the electronics and information industries, an Industrial Technology Research Institute (ITRI) official said in Taipei yesterday.
By doing so, it could attract international companies to set up bioinformatics research and development (R&D) centers in Taiwan, Hsieh Liang-han (謝良翰), general director of ITRI’s international business center told the Taipei Times yesterday.
“Taiwan’s strength lies in its information and communications technology [ICT] industry and basic research. I believe if the nation’s biotechnology industry can integrate with the ICT industry, it will begin to develop at a faster pace,” Hsieh said at the sidelines of the 2008 APEC Biotechnology Conference organized by the ITRI.
What Taiwan lacks now in the field of biotechnology is the “link” in the industry value chain, Hsieh said.
For example, Taiwan may be strong in the basic research of liver disease, but the local biotech industry is still in the development stage, Hsieh said.
Stanley Chang (張世忠), chairman of the Taipei-based Medigen Biotechnology Corp (基亞生物科技), who was invited to give a speech at the conference, agreed.
“Taiwan is strong in a couple of research topics in the world, with liver cancer being our strongest point. Integrating Taiwan’s precision equipment and biotechnology is a new direction that we can seriously consider,” Chang told the Taipei Times yesterday after his speech.
To attract international companies, such as the Switzerland-based pharmaceutical companies Novartis International AG and Roche Applied Science to set up their R&D centers in Taiwan, Hsieh said the government would have to first set up a few centers of excellence, such as in liver disease.
The conference took place at the Taipei International Convention Center yesterday, with “adding value to biomedical translational medicine” being its main theme. Hsieh said ITRI’s international business center would focus on linking the laboratory and the “patient’s bedside” this year — often referred to as “bench to bedside” — and encouraging transregional cooperation.
Biotech experts from seven foreign countries were invited by ITRI to share their experiences and national policies regarding translational medicine at the conference yesterday, in an effort to foster cross-regional interaction and translational medicine collaboration in the Asia-Pacific region.
BUSINESS UPDATE: The iPhone assembler said operations outlook is expected to show quarter-on-quarter and year-on-year growth for the second quarter Hon Hai Precision Industry Co (鴻海精密) yesterday reported strong growth in sales last month, potentially raising expectations for iPhone sales while artificial intelligence (AI)-related business booms. The company, which assembles the majority of Apple Inc’s smartphones, reported a 19.03 percent rise in monthly sales to NT$510.9 billion (US$15.78 billion), from NT$429.22 billion in the same period last year. On a monthly basis, sales rose 14.16 percent, it said. The company in a statement said that last month’s revenue was a record-breaking April performance. Hon Hai, known also as Foxconn Technology Group (富士康科技集團), assembles most iPhones, but the company is diversifying its business to
Apple Inc has been developing a homegrown chip to run artificial intelligence (AI) tools in data centers, although it is unclear if the semiconductor would ever be deployed, the Wall Street Journal reported on Monday. The effort would build on Apple’s previous efforts to make in-house chips, which run in its iPhones, Macs and other devices, according to the Journal, which cited unidentified people familiar with the matter. The server project is code-named ACDC (Apple Chips in Data Center) within the company, aiming to utilize Apple’s expertise in chip design for the company’s server infrastructure, the newspaper said. While this initiative has been
GlobalWafers Co (環球晶圓), the world’s No. 3 silicon wafer supplier, yesterday said that revenue would rise moderately in the second half of this year, driven primarily by robust demand for advanced wafers used in high-bandwidth memory (HBM) chips, a key component of artificial intelligence (AI) technology. “The first quarter is the lowest point of this cycle. The second half will be better than the first for the whole semiconductor industry and for GlobalWafers,” chairwoman Doris Hsu (徐秀蘭) said during an online investors’ conference. “HBM would definitely be the key growth driver in the second half,” Hsu said. “That is our big hope
The consumer price index (CPI) last month eased to 1.95 percent, below the central bank’s 2 percent target, as food and entertainment cost increases decelerated, helped by stable egg prices, the Directorate-General of Budget, Accounting and Statistics (DGBAS) said yesterday. The slowdown bucked predictions by policymakers and academics that inflationary pressures would build up following double-digit electricity rate hikes on April 1. “The latest CPI data came after the cost of eating out and rent grew moderately amid mixed international raw material prices,” DGBAS official Tsao Chih-hung (曹志弘) told a news conference in Taipei. The central bank in March raised interest rates by